Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania

被引:93
作者
Frey, Benicio Noronha
Martins, Marcio Rodrigo
Petronilho, Fabricia Cardoso
Dal-Pizzol, Felipe
Quevedo, Joao
Kapczinski, Flavio [1 ]
机构
[1] Hosp Clin Porto Alegre, Ctr Pesquisa, Bipolar Disorders Program, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Sul, Dept Biochem, ICBS, BR-90046900 Porto Alegre, RS, Brazil
[3] Univ Extremo Sul Catarinense, Neurosci Lab, Criciuma, Brazil
[4] UFRGS, ICBS, Dept Biochem, Ctr Studies Oxidat Stress, Oporto, Portugal
[5] UNESC, Expt Physiopathol Lab, Criciuma, Brazil
关键词
amphetamine; animal model; bipolar disorder; mania; oxidative stress;
D O I
10.1111/j.1399-5618.2006.00318.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Acute mania can be modeled in animals using D-amphetamine (AMPH). Acute AMPH injections are associated with monoamine depletion, loss of neurofilaments and neurite degeneration. However, the precise mechanisms underlying AMPH-induced neurotoxicity are still unclear. Several studies have demonstrated that oxidative stress may play a role in the behavioral and neurochemical changes observed after AMPH administration. Methods: The effects of a single and repeated injections (seven daily injections) of AMPH administered intraperitonially on locomotion and the production of lipid and protein oxidative markers in rat cortex, striatum and hippocampus were assessed. Locomotion was assessed in an open-field task and markers of oxidative stress were assessed in brain tissue. Results: Both single and repeated injections of AMPH increased protein carbonyl formation in rat brain. Repeated exposure to AMPH induced an additional increase in thiobarbituric acid reactive species in brain tissue. Conclusions: Longer periods of exposure to AMPH were associated with increased oxidative stress in rat brain. This adds to the notion that repeated manic episodes may be associated with greater brain damage and, therefore, poorer outcomes.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 34 条
[1]   EFFECTS OF REPEATED ADMINISTRATION OF A HIGH-DOSE OF METHAMPHETAMINE ON DOPAMINE AND GLUTAMATE RELEASE IN RAT STRIATUM AND NUCLEUS-ACCUMBENS [J].
ABEKAWA, T ;
OHMORI, T ;
KOYAMA, T .
BRAIN RESEARCH, 1994, 643 (1-2) :276-281
[2]   The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex [J].
Açikgöz, O ;
Gönenç, S ;
Kayatekin, BM ;
Pekçtin, C ;
Uysal, N ;
Dayi, A ;
Semin, I ;
Güre, A .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2000, 10 (05) :415-418
[3]   Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum [J].
Açikgöz, O ;
Gönenç, S ;
Kayatekin, BM ;
Uysal, N ;
Pekçetin, Ç ;
Semin, I ;
Güre, A .
BRAIN RESEARCH, 1998, 813 (01) :200-202
[4]   Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity [J].
Battaglia, G ;
Fornai, F ;
Busceti, CL ;
Aloisi, G ;
Cerrito, F ;
De Blasi, A ;
Melchiorri, D ;
Nicoletti, F .
JOURNAL OF NEUROSCIENCE, 2002, 22 (06) :2135-2141
[5]   Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade [J].
Beaulieu, JM ;
Sotnikova, TD ;
Yao, WD ;
Kockeritz, L ;
Woodgett, JR ;
Gainetdinov, RR ;
Caron, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :5099-5104
[6]   Medical progress: Bipolar disorder [J].
Belmaker, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :476-486
[7]   Reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives [J].
Benes, FM ;
Kwok, EW ;
Vincent, SL ;
Todtenkopf, MS .
BIOLOGICAL PSYCHIATRY, 1998, 44 (02) :88-97
[8]   Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress [J].
Brown, JM ;
Yamamoto, BK .
PHARMACOLOGY & THERAPEUTICS, 2003, 99 (01) :45-53
[9]   Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration [J].
Burrows, KB ;
Gudelsky, G ;
Yamamoto, BK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (01) :11-18
[10]  
Castillo M, 2000, AM J NEURORADIOL, V21, P832